Company / PP&E (Net)
IDEAYA Biosciences, Inc. PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$8.2M
FY2025
5-year range
$4.8M / $9.0M
FY2021-FY2025
Trend
-8.4%
vs FY2024
Sector context
#99 of 193
Health Care
What the data says
At $8M, IDEAYA Biosciences, Inc.'s pp&e (net) ranks #99 of 193 in the Health Care sector. PP&E (Net) has fluctuated over the past 8 years, ranging from $4M in FY2020 to $9M in FY2024.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +14.0%.
Improved from $6M to $8M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
#99 of 193 in Health CareTop 51% of 193This company $8.2M Sector average $777.6M
▼
-98.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.0%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 8.4% year-over-year.
- Ranks #99 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2M | -8.4% |
| FY2024 | $9.0M | +45.5% |
| FY2023 | $6.2M | -5.3% |
| FY2022 | $6.5M | +36.7% |
| FY2021 | $4.8M | +11.5% |
| FY2020 | $4.3M | -8.0% |
| FY2019 | $4.6M | -9.9% |
| FY2018 | $5.2M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026